/HROW

Harrow Inc

HROW

$34.48USD↓-5.74%-2.10 today

MARKET CAP

1.3B

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$34 – $37

52W RANGE

$29

$55

AI Summary

Stalk

TrimMedium

The stock is in a Stage 4 decline with active lower highs/lower lows and a Bearish Pivot Point indicating failed upside control. Price remains below declining short-term EMAs and the 50 SMA, but proximity to immediate support and neutral RSI suggest a potential pause or bounce, making deferred selling preferred until resistance is retested.

↑IHEEZO trial shows 58% lower injection discomfort vs peers
↑Revenue to grow at 28.2% CAGR, aiming profitability by 2027
↓Negative earnings yield and –37.3 P/E highlight valuation strain

Full analysis →

Buying

5

institutions

Selling

3

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	2.74 M	116.37 M	+187.36 K	+29.3%	0.00%
CA Citadel Advisors LLC Q2 2026	BUY	984.27 K	41.80 M	+412.92 K	+107.5%	0.00%
MM Millennium Management LLC Q2 2026	BUYNEW	84.18 K	3.58 M	+84.18 K	+0.0%	0.00%
RT Renaissance Technologies LLC Q2 2026	SELL	44.62 K	1.89 M	+-39.96 K	-36.5%	0.00%
JC Jpmorgan Chase & Co Q2 2026	SELL	32.62 K	1.39 M	+-3.77 K	+15.1%	0.00%
JH Janus Henderson Group Plc Q1 2026	BUY	27.00 K	952.43 K	+13.50 K	+43.9%	0.00%
RC Rockefeller Capital Management L.P. Q2 2026	BUY	357.00	15.16 K	+150.00	+107.7%	0.00%
AC Aqr Capital Management LLC Q2 2026	SELL	0.00	0.00	+-6.55 K	-100.0%	0.00%